The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness

代谢酶己糖激酶2在急性髓系白血病(AML)和正常造血干细胞及祖细胞中定位于细胞核内,以维持干性。

阅读:4
作者:Geethu Emily Thomas # ,Grace Egan # ,Laura García-Prat ,Aaron Botham ,Veronique Voisin ,Parasvi S Patel ,Fieke W Hoff ,Jordan Chin ,Boaz Nachmias ,Kerstin B Kaufmann ,Dilshad H Khan ,Rose Hurren ,Xiaoming Wang ,Marcela Gronda ,Neil MacLean ,Cristiana O'Brien ,Rashim P Singh ,Courtney L Jones ,Shane M Harding ,Brian Raught ,Andrea Arruda ,Mark D Minden ,Gary D Bader ,Razq Hakem ,Steve Kornblau ,John E Dick ,Aaron D Schimmer

Abstract

Mitochondrial metabolites regulate leukaemic and normal stem cells by affecting epigenetic marks. How mitochondrial enzymes localize to the nucleus to control stem cell function is less understood. We discovered that the mitochondrial metabolic enzyme hexokinase 2 (HK2) localizes to the nucleus in leukaemic and normal haematopoietic stem cells. Overexpression of nuclear HK2 increases leukaemic stem cell properties and decreases differentiation, whereas selective nuclear HK2 knockdown promotes differentiation and decreases stem cell function. Nuclear HK2 localization is phosphorylation-dependent, requires active import and export, and regulates differentiation independently of its enzymatic activity. HK2 interacts with nuclear proteins regulating chromatin openness, increasing chromatin accessibilities at leukaemic stem cell-positive signature and DNA-repair sites. Nuclear HK2 overexpression decreases double-strand breaks and confers chemoresistance, which may contribute to the mechanism by which leukaemic stem cells resist DNA-damaging agents. Thus, we describe a non-canonical mechanism by which mitochondrial enzymes influence stem cell function independently of their metabolic function.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。